Product Name

  • Name

    Etoricoxib

  • EINECS 682-421-5
  • CAS No. 202409-33-4
  • Article Data44
  • CAS DataBase
  • Density 1.298 g/cm3
  • Solubility
  • Melting Point 134-135 °C
  • Formula C18H15ClN2O2S
  • Boiling Point 510 °C at 760 mmHg
  • Molecular Weight 358.848
  • Flash Point 262.2 °C
  • Transport Information
  • Appearance off-white powder
  • Safety 36/37-45
  • Risk Codes 22-24
  • Molecular Structure Molecular Structure of 202409-33-4 (Etoricoxib)
  • Hazard Symbols T
  • Synonyms 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine;Algix;Arcoxia;Etobrix;Etocox;
  • PSA 68.30000
  • LogP 5.25670

Synthetic route

etoricoxib hydrochloride
202409-40-3

etoricoxib hydrochloride

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With sodium hydrogencarbonate In dichloromethane; water at 10 - 20℃; for 0.5h; Reagent/catalyst; Large scale;96.5%
4-(5-chloro-6'-methyl-[2,3'-bipyridin]-3-yl)benzenesulfinic acid

4-(5-chloro-6'-methyl-[2,3'-bipyridin]-3-yl)benzenesulfinic acid

methyl iodide
74-88-4

methyl iodide

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Stage #1: 4-(5-chloro-6'-methyl-[2,3'-bipyridin]-3-yl)benzenesulfinic acid With tetra-(n-butyl)ammonium iodide In tetrahydrofuran at 65℃; for 0.333333h;
Stage #2: methyl iodide In tetrahydrofuran at 65℃; for 2h; Cooling with liquid nitrogen;
95%
5-chloro-3-(4-methylsulphonyl)phenyl-2-(2-methyl-5-pyridinyl)pyridine
292067-97-1

5-chloro-3-(4-methylsulphonyl)phenyl-2-(2-methyl-5-pyridinyl)pyridine

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With sodium molybdate; sulfuric acid; dihydrogen peroxide In methanol at 55℃; for 0.25h;94%
With oxygen; uranyl(VI) acetate dihydrate In o-xylene; water; acetonitrile at 20℃; under 760.051 Torr; Schlenk technique; Irradiation;91%
With diethylene glycol dibutyl ether; oxygen at 110℃; for 20h; Green chemistry;78%
5-chloro-1,2,3-triazine

5-chloro-1,2,3-triazine

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With potassium hydroxide In acetonitrile at 80℃; for 8h; Concentration; Inert atmosphere;89%
With caesium carbonate In tetrahydrofuran at 20℃; for 3h;82%
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

N-(2-chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V)

N-(2-chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V)

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Stage #1: 1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone With potassium tert-butylate In tetrahydrofuran at 0 - 20℃; for 0.25h; Inert atmosphere;
Stage #2: N-(2-chloro-3-(dimethylamino)allylidene)-N-methylmethanaminium hexafluorophosphate(V) With acetic acid In tetrahydrofuran at 20 - 25℃; for 2.5h; Inert atmosphere;
Stage #3: With ammonium hydroxide In tetrahydrofuran at 60 - 65℃; for 1.5h; Inert atmosphere;
84.4%
With methanesulfonic acid; ammonium acetate; propionic acid In toluene at 25 - 75℃; for 14 - 16h; Reflux;
2,5-dichloro-3-[4-(methylsulfonyl)phenyl]pyridine
202409-86-7

2,5-dichloro-3-[4-(methylsulfonyl)phenyl]pyridine

C15H27BNO3(1-)*Li(1+)

C15H27BNO3(1-)*Li(1+)

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
palladium79%
2-chloro-1,3-(bis-piperidinyl)trimethinium hexafluorophosphate

2-chloro-1,3-(bis-piperidinyl)trimethinium hexafluorophosphate

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Stage #1: 1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone With potassium tert-butylate In tetrahydrofuran at 25 - 30℃; for 1h;
Stage #2: 2-chloro-1,3-(bis-piperidinyl)trimethinium hexafluorophosphate In tetrahydrofuran at 30 - 55℃; Product distribution / selectivity;
75.9%
2-chloro-3-hydroxyacrylaldehyde

2-chloro-3-hydroxyacrylaldehyde

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With methanesulfonic acid In 1,2-dichloro-ethane at 80 - 100℃; for 24h;73%
(2Z,4Z)-4-Chloro-5-dimethylamino-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-penta-2,4-dien-1-one

(2Z,4Z)-4-Chloro-5-dimethylamino-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-penta-2,4-dien-1-one

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With ammonium hydroxide In tetrahydrofuran at 60 - 65℃; Inert atmosphere;72.1%
With ammonium hydroxide In tetrahydrofuran for 5h; cyclocondensation; Heating;
5-chloro-3-(4-(methylsulfonyl)phenyl)pyridin-2-yl fluorosulfate

5-chloro-3-(4-(methylsulfonyl)phenyl)pyridin-2-yl fluorosulfate

(6-methylpyridin-3-yl)boronic acid
659742-21-9

(6-methylpyridin-3-yl)boronic acid

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With tetrakis(triphenylphosphine) palladium(0); sodium hydrogencarbonate In 1,4-dioxane; water at 80℃; for 8h; Suzuki Coupling; chemoselective reaction;71%
5-bromo-2-methylpyridine
3430-13-5

5-bromo-2-methylpyridine

2-(allylsulfonyl)-5-chloro-3-[4-(methylsulfonyl)phenyl]pyridine

2-(allylsulfonyl)-5-chloro-3-[4-(methylsulfonyl)phenyl]pyridine

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With di-tert-butyl(methyl)phosphonium tetrafluoroborate salt; palladium diacetate; caesium carbonate In 1,4-dioxane at 120℃; for 18h; Inert atmosphere;69%
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

2-chloroaminoacrolein

2-chloroaminoacrolein

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With methanesulfonic acid; propionic acid In toluene at 114℃; for 12h; Heating / reflux;65%
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

chloromalonaldehyde

chloromalonaldehyde

A

3,5-dichloropyridine
2457-47-8

3,5-dichloropyridine

B

etoricoxib
202409-33-4

etoricoxib

C

1-(6-methyl-3-pyridinyl)-3-(4-methanesulfonylphenyl)furan

1-(6-methyl-3-pyridinyl)-3-(4-methanesulfonylphenyl)furan

Conditions
ConditionsYield
With ammonium acetate In propionic acid at 125℃;A n/a
B 62%
C 15%
5-chloro-3-[4-(methylsulfonyl)phenyl]pyridin-2-yl trifluoromethanesulfonate

5-chloro-3-[4-(methylsulfonyl)phenyl]pyridin-2-yl trifluoromethanesulfonate

(6-methylpyridin-3-yl)boronic acid
659742-21-9

(6-methylpyridin-3-yl)boronic acid

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With palladium diacetate; sodium hydrogencarbonate; tricyclohexylphosphine In 1,4-dioxane; water at 80℃; for 1.5h; Suzuki-Miyaura Coupling; Sealed tube; Inert atmosphere; Schlenk technique;60%
With tetrakis(triphenylphosphine) palladium(0); sodium hydrogencarbonate In 1,4-dioxane; water at 80℃; for 3h; Inert atmosphere; Schlenk technique; Sealed tube;52%
2,3-dichloroacrolein
99414-75-2

2,3-dichloroacrolein

Lithium; (Z)-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethenolate

Lithium; (Z)-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethenolate

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Stage #1: 2,3-dichloroacrolein; Lithium; (Z)-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-ethenolate In tetrahydrofuran
Stage #2: With ammonia In tetrahydrofuran Heating; Further stages.;
58%
2-bromo-5-chloro-3-(4-(methylsulfonyl)phenyl)pyridine
202409-81-2

2-bromo-5-chloro-3-(4-(methylsulfonyl)phenyl)pyridine

(6-methylpyridin-3-yl)boronic acid
659742-21-9

(6-methylpyridin-3-yl)boronic acid

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With copper(l) iodide; tetrakis(triphenylphosphine) palladium(0); cesium fluoride In 1,4-dioxane for 20h; Concentration; Suzuki Coupling; Inert atmosphere; Reflux;55%
3-bromo-5-chloro-6'-methyl-2,3'-bipyridine

3-bromo-5-chloro-6'-methyl-2,3'-bipyridine

4-methanesulphonylphenylboronic acid
149104-88-1

4-methanesulphonylphenylboronic acid

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With bis-triphenylphosphine-palladium(II) chloride; potassium carbonate In 1,4-dioxane at 100℃;54%
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

3-anilido-2-chloro-acrolein

3-anilido-2-chloro-acrolein

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With ammonium acetate In propionic acid Heating;47%
(2Z,4Z)-4-Chloro-5-dimethylamino-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-penta-2,4-dien-1-one

(2Z,4Z)-4-Chloro-5-dimethylamino-2-(4-methanesulfonyl-phenyl)-1-(6-methyl-pyridin-3-yl)-penta-2,4-dien-1-one

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
With ammonium hydroxide In tetrahydrofuran for 3h; Heating;8.42 g
2-methyl-5-formylpyridine
53014-84-9

2-methyl-5-formylpyridine

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 7 steps
1: 46.5 g / isopropyl acetate / 60 °C
2: 46.5 g / isopropyl acetate / 60 - 65 °C
3: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
4: 24.91 g / aq. HCl / 25 - 45 °C
5: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
6: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
7: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 5 steps
1: 46.5 g / isopropyl acetate / 60 °C
2: 46.5 g / isopropyl acetate / 60 - 65 °C
3: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
4: 24.91 g / aq. HCl / 25 - 45 °C
5: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 5 steps
1: 46.5 g / isopropyl acetate / 60 °C
2: 46.5 g / isopropyl acetate / 60 - 65 °C
3: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
4: 24.91 g / aq. HCl / 25 - 45 °C
5: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
Methyl 6-methylnicotinate
5470-70-2

Methyl 6-methylnicotinate

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
3: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
4: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 2 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
4-(methylsulfonyl)phenylacetic acid
90536-66-6

4-(methylsulfonyl)phenylacetic acid

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
3: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
4: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 2 steps
1: 58 percent / t-BuMgCl / tetrahydrofuran / 50 °C
2: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
N-methoxy-N-methyl-6-methylnicotinamide
221615-71-0

N-methoxy-N-methyl-6-methylnicotinamide

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 5 steps
1: 80 percent / tetrahydrofuran; toluene / 1 h / -10 °C
2: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
3: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
4: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
5: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: 80 percent / tetrahydrofuran; toluene / 1 h / -10 °C
2: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
3: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 3 steps
1: 80 percent / tetrahydrofuran; toluene / 1 h / -10 °C
2: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
3: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
1-(6-methyl-3-pyridinyl)-2-[4-(methyl sulfide)phenyl]ethanone
221615-72-1

1-(6-methyl-3-pyridinyl)-2-[4-(methyl sulfide)phenyl]ethanone

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
2: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
3: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
4: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 2 steps
1: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
2: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 2 steps
1: 89 percent / sodium tungstate; aq. H2O2 / aq. H2SO4; methanol / 55 °C
2: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone
221615-75-4

1-(6-methyl-3-pyridinyl)-2-[4-(methylsulfonyl)phenyl]ethanone

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
2: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
3: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 3 steps
1: t-BuOK / tetrahydrofuran / 0.75 h / 25 °C
2: TFA; AcOH / tetrahydrofuran / 0.75 h / 25 - 30 °C
3: aq. NH3 / tetrahydrofuran / 5 h / Heating
View Scheme
Multi-step reaction with 2 steps
1.1: potassium tert-butylate / tetrahydrofuran / 30 - 55 °C / Large scale
1.2: Large scale
2.1: sodium hydroxide; water / 25 - 35 °C
View Scheme
[1-(6-Methyl-pyridin-3-yl)-meth-(E)-ylidene]-phenyl-amine

[1-(6-Methyl-pyridin-3-yl)-meth-(E)-ylidene]-phenyl-amine

etoricoxib
202409-33-4

etoricoxib

Conditions
ConditionsYield
Multi-step reaction with 6 steps
1: 46.5 g / isopropyl acetate / 60 - 65 °C
2: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
3: 24.91 g / aq. HCl / 25 - 45 °C
4: t-BuOK / tetrahydrofuran / 0.75 h / 20 °C
5: AcOH; TFA / tetrahydrofuran / 0.75 h / 25 - 30 °C
6: 8.42 g / aq. NH4OH / tetrahydrofuran / 3 h / Heating
View Scheme
Multi-step reaction with 4 steps
1: 46.5 g / isopropyl acetate / 60 - 65 °C
2: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
3: 24.91 g / aq. HCl / 25 - 45 °C
4: 62 percent / NH4OAc / propionic acid / 125 °C
View Scheme
Multi-step reaction with 4 steps
1: 46.5 g / isopropyl acetate / 60 - 65 °C
2: t-BuOK / propan-2-ol; tetrahydrofuran / 0.5 h / 25 °C
3: 24.91 g / aq. HCl / 25 - 45 °C
4: 47 percent / NH4OAc / propionic acid / Heating
View Scheme
2-(1-cyclohexenyl)ethylamine
3399-73-3

2-(1-cyclohexenyl)ethylamine

etoricoxib
202409-33-4

etoricoxib

N-(2-(cyclohex-1-en-1-yl)ethyl)-6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine

N-(2-(cyclohex-1-en-1-yl)ethyl)-6'-methyl-3-(4-(methylsulfonyl)phenyl)-[2,3'-bipyridin]-5-amine

Conditions
ConditionsYield
With C47H70BrO4PPdSi; sodium t-butanolate In tetrahydrofuran at 20℃; for 1h; Schlenk technique; Inert atmosphere; Sealed tube;97%

Etoricoxib Chemical Properties

Molecule structure of Etoricoxib (CAS NO.202409-33-4):

IUPAC Name: 5-Chloro-2-(6-methylpyridin-3-yl)-3-(4-methylsulfonylphenyl)pyridine 
Molecular Weight: 358.8419 g/mol
Molecular Formula: C18H15ClN2O2
Density: 1.298 g/cm3 
Melting Point: 134-135 °C
Boiling Point: 510 °C at 760 mmHg 
Flash Point: 262.2 °C
Index of Refraction: 1.6
Molar Refractivity: 94.65 cm3
Molar Volume: 276.4 cm3
Surface Tension: 49.6 dyne/cm 
Enthalpy of Vaporization: 75.11 kJ/mol
Vapour Pressure: 5.17E-10 mmHg at 25 °C
XLogP3-AA: 3.3
H-Bond Acceptor: 4
Rotatable Bond Count: 3
Exact Mass: 358.054276
MonoIsotopic Mass: 358.054276
Topological Polar Surface Area: 59.9
Heavy Atom Count: 24
Canonical SMILES: CC1=NC=C(C=C1)C2=NC=C(C=C2C3=CC=C(C=C3)S(=O)(=O)C)Cl
InChI: InChI=1S/C18H15ClN2O2S/c1-12-3-4-14(10-20-12)18-17(9-15(19)11-21-18)13-5-7-16(8-6-13)24(2,22)23/h3-11H,1-2H3
InChIKey: MNJVRJDLRVPLFE-UHFFFAOYSA-N
Product Categories: Osteoarthritis and Rheumatoid Arthritis; Intermediates & Fine Chemicals; Pharmaceuticals

Etoricoxib Uses

 Etoricoxib (CAS NO.202409-33-4) is a non-steroidal anti-inflammatory drug (NSAID). It is used for treating the diseases such as rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain and gout.

Etoricoxib Specification

 Etoricoxib (CAS NO.202409-33-4) is also named as 5-Chloro-6'-methyl-3-(p-(methylsulfonyl)phenyl)-2,3'-bipyridine ; Arcoxia ; Etoxib ; Etropain ; Kingcox ; L-791456 ; MK 0663 ; MK 663 ; Tauxib ; Torcoxia ; UNII-WRX4NFY03R ; 2,3'-Bipyridine, 5-chloro-6'-methyl-3-(4-(methylsulfonyl)phenyl)- . Etoricoxib (CAS NO.202409-33-4) is off-white powder.

Post buying leads

About|Contact|Cas|Product Name|Molecular|Country|Encyclopedia

Message|New Cas|MSDS|Service|Advertisement|CAS DataBase|Article Data|Manufacturers | Chemical Catalog

©2008 LookChem.com,License: ICP

NO.:Zhejiang16009103

complaints:service@lookchem.com Desktop View